Harpoon Medical Device

DEVICE2 trials

Sponsors

Edwards Lifesciences

Conditions

Mitral Valve InsufficiencyMitral Valve ProlapseMitral Valve Regurgitation

Unknown Phase

CE Mark Study for the Harpoon Medical Device in Poland

CompletedNCT02432196

Edwards LifesciencesMitral Valve Insufficiency, Mitral Valve Prolapse, Mitral Valve Regurgitation

Start: 2015-12-11End: 2022-11-16Updated: 2024-01-22

Safety and Early Feasibility Study of the Harpoon Medical Device (EFS)

CompletedNCT02771275

Edwards LifesciencesMitral Valve Insufficiency, Mitral Valve Prolapse, Mitral Valve Regurgitation

Start: 2015-02-15End: 2021-07-16Updated: 2024-01-22

Related Papers

Safety and performance of a novel transventricular beating heart mitral valve repair system: 1-year outcomes

European Journal of Cardio-Thoracic Surgery2020-06-2936 citations

Duration of Prehospital Cardiopulmonary Resuscitation and Favorable Neurological Outcomes for Pediatric Out-of-Hospital Cardiac Arrests

Circulation2016-10-2548 citations

Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device

Circulation2016-07-1984 citations